Christine Carberry

2017

In 2017, Christine Carberry earned a total compensation of $1.8M as Chief Operating Officer at Keryx Biopharmaceuticals.

Compensation breakdown

Bonus$14,630
Non-Equity Incentive Plan$146,300
Option Awards$729,742
Salary$357,718
Stock Awards$511,700
Other$8,019
Total$1,768,109

Carberry received $729.7K in option awards, accounting for 41% of the total pay in 2017.

Carberry also received $14.6K in bonus, $146.3K in non-equity incentive plan, $357.7K in salary, $511.7K in stock awards and $8K in other compensation.

Rankings

In 2017, Christine Carberry's compensation ranked 6,118th out of 14,666 executives tracked by ExecPay. In other words, Carberry earned more than 58.3% of executives.

ClassificationRankingPercentile
All
6,118
out of 14,666
58th
Division
Manufacturing
2,248
out of 5,768
61st
Major group
Chemicals And Allied Products
709
out of 2,074
66th
Industry group
Drugs
546
out of 1,730
68th
Industry
Pharmaceutical Preparations
429
out of 1,329
68th
Source: SEC filing on May 31, 2018.

Carberry's colleagues

We found four more compensation records of executives who worked with Christine Carberry at Keryx Biopharmaceuticals in 2017.

2017

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2017

John Neylan

Keryx Biopharmaceuticals

Chief Medical Officer

2017

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

2017

Brian Adams

Keryx Biopharmaceuticals

General Counsel

You may also like